After successfully completing its halving, Bitcoin is sitting strongly at $66,000, and crypto stocks are in celebration mode
Pharmacy benefit managers have generally not added oral GLP-1s for obesity to their formularies, so most utilization has come from patients paying out of pocket.
Now, basically, everyones coming to the middle and asking, How do we responsibly cover these drugs? Part of responsible coverage, Inkinen said, is providing other forms of support to patients who stop using GLP-1 medications, by choice or otherwise
I was tired of feeling inflamed, discouraged, and stuck in the same loop over and over again
It also helps to boost the immune system by promoting the growth and activity of immune cells